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Abstract
Background: Heart transplantation remains the gold standard for end-stage heart failure, with current ex vivo organ
storage times limited to 4 to 6 h before critical tissue damage occurs. Many preservation solutions exist in an attempt to
limit both ischemic and reperfusion damage. In order to compare the effects of various storage solutions, mitochondrial
function can be used to provide a sensitive analysis of cellular metabolic function.
Methods: Experimental plates were seeded with cardiac myoblasts and kept in suspended animation for either
4 or 8 h at either 4o or 21 °C, in Celsior®, Perfadex®, or Somah storage solutions. Cells were then reanimated for
1 h at 37 °C to simulate a reperfusion or clinical transplant scenario. Cellular bioenergetics were measured immediately
thereafter to examine biochemical differences between preservation solutions and their effectiveness on preserving
metabolic function.
Results: The oxygen consumption rates of Somah solution were significantly higher than Celsior® and Perfadex®
at 4 °C, with the exception of Perfadex® at 4o for 4 h. This effect was sustained up to 8 h. At 21 °C, oxygen
consumption rates of Somah solution are significantly higher than Celsior® and Perfadex® at basal conditions after
4 h, but this effect is not sustained after 8 h.
Conclusions: The purpose of this experiment was to study the efficacy of various preservation solutions on a
mitochondrial level. The significantly higher oxygen consumption rates of Somah at 4 °C suggests that Somah
solution may have the ability to protect cellular mitochondrial integrity, improve transplanted organ function by
reducing ischemic-reperfusion injury, and thereby improve transplant outcomes. Given that Somah offers benefits
over Celsior® and Perfadex® at 4 °C, it should be a target in future organ preservation solution research.
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Background
The gold standard for patients suffering from end-stage
heart failure remains heart transplantation. With the
number of patients requiring transplants growing and
the available organs remaining constant, there is a need
for improved donor organ and graft preservation
methods to extend the life of donor organs [1]. Conserv-
ing organ viability outside of an organism can be
accomplished by warm or cold storage, with or without
perfusion. Currently, the standard approach in heart
preservation is cold static storage, often supplemented
by the use of preservation solutions [2]. These ap-
proaches have allowed for an ex vivo storage time of
about 4–6 h before critical tissue damage occurs [3].
Preservation of organs for longer than 4–6 h results in
increased ROS levels, ATP depletion, Na+/K+ ATPase
alterations, mitochondrial disturbances, accumulation
of xanthine oxidase, and dysregulation of Ca2+ homeo-
stasis that will negatively effect cellular viability [2, 4].
Under normal physiological conditions, the heart utilizes
ATP as energy for the Na+/K+ ATPase, both of which are
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required for sustained myocardial contractility. During is-
chemia, ATP levels decrease while intracellular H+ in-
creases due to the shift from aerobic to anaerobic
respiration via glycolysis and lactate production. ATPase
pumps that maintain homeostasis become dysfunctional
as the synthesis of ATP slows. Disruption of these ATPase
pumps in the mitochondria can be measured experimen-
tally through examining extracellular flux and mitochon-
drial respiration. In an attempt to avoid the negative
effects of decreased ATPase pump efficacy, both the cold
storage approach and utilization of storage solutions
exists.
Cellular metabolic demand decreases as much as 12-fold
under hypothermic conditions at 4 °C [5], but metabolic
processes persist and will continue to result in cellular
damage. Though warm preservation might result in injury
from non-controlled warm ischemic periods [2], it is less
researched and could be a more effective and sophisticated
storage method [6]. Regardless of storage temperature dur-
ing perfused or static storage, preservation solutions such
as Celsior®, Perfadex®, and Somah storage solutions are
commonly used to decrease ischemic reperfusion injury
(IRI) from reactive oxygen species (ROS), prevent intra-
and extracellular swelling, and minimize energy usage by
lowering metabolic demand. The conservation of mito-
chondrial bioenergetic measurements such as these is im-
portant for improving organ transplant outcomes during
static storage. During storage and upon reperfusion, IRI
can be attenuated by using storage solutions such as
University of Wisconsin (UW) solution [7]. However,
UW contains high molecular weight compounds such
as hydroxyethyl starch that resulted in a highly viscous
solution that is linked to organ dysfunction. Newer
alternatives including Celsior®, Perfadex®, and Somah
have since been created to allow for reliable organ pres-
ervation up to 6 h by providing immunosuppressant
and antioxidant properties that minimize IRI [4, 7].
There are numerous organ storage solutions, with many
new solutions currently in development. Somah is a novel
solution that acts to maintain membrane polarity by
allowing higher levels of high-energy phosphates to be
generated through the glycolytic pathway during preserva-
tion, and mitigates the consequences of IRI overall [8].
Somah was developed to meet the energy requirements of
cardiomyocytes and coronary endothelium, in addition to
priming the organ with substrates and metabolites during
storage to facilitate resumption of biochemical, physio-
logical, and mechanical work upon post-transplantation
reperfusion [8]. The differences between Somah, Celsior®,
and Perfadex® are summarized in Table 1. Properties of
these three preservation solutions are fairly similar,
however, Somah contains many additional protective and
unique substrates, such as adenosine, insulin, and abscor-
bic acid, among others [8]. For these reasons, bioenergetic
profiles were generated to further explore mitochondrial
physiology and the effects of storage solutions on organ
preservation.
In the present study, we sought to compare the biochem-
ical differences between organ preservation solutions and
their effectiveness on preserving cellular metabolic and
mitochondrial function. Our protocol involves putting cells
in suspended animation for 4 to 8 h at 4o or 21 °C, reani-
mating the cells over 1 h at 37 °C with regular media, and
then immediately recording the bioenergetics thereafter.
This study evaluates mitochondrial function under clinically
relatable conditions, investigates mitochondrial safeguard-
ing, and examines the bioenergetic state of cells after expos-
ure to Celsior®, Perfadex®, and Somah storage solutions.
Table 1 Comparison of organ preservation solutions
Celsiora Perfadexa Somahb
IC/EX EX EX EX
Na+ 100 138 125
K+ 15 6 7
Impermeant/Colloid LactoB, mannitol Dextran LactoB, mannitol
Buffer Histidine Phos Bicarb
Antioxidant GSH, mannitol - GSH, mannitol
Osmolarity (mOsm/L) 320 292 305
Ca2+ 0.25 0.25
Mg2+ 13 0.8 13
CI- - 142 -
Glucose - 5 11
Others SO4
2-0.8 dextran 40 g/L 2 mmol/L adenosine insulin 10 mg/ml
1 mmol abscorbic acid
All units expressed in mmol/L unless otherwise indicated
Source aReference [8]; bReference [5]
Abbreviations: IC intracellular, EX extracellular, Und undetermined, LactoB lactobionate, HES hydroxyethyl starch, Phos phosphate, Bicarb bicarbonate, GSH glutathione
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Methods
Microplate coating
Cell-Tak was purchased from Corning (Product #354240).
Cell-Tak was prepared in a 2:1 ratio to 1 M NaOH. The
wells of a 96-well Seahorse microplate (Seahorse Bio-
science, North Billerica, MA) were coated with 40 μl
Cell-Tak solution and the plate was allowed to dry at
room temperature for 20 min. Following the drying
period, wells were aspirated and washed twice with 1x
DMEM. The coated microplates were stored at 4 °C
and used within 72 h.
Preservation solution treatments
Rat embryonic myoblasts, H9C2s (ATCC® CRL1446™),
were maintained at standard cell culture conditions in
DMEMmedium enriched with 10% FBS (Seradigm, Product
# 1400-500), 5% L-glutamine (Corning, Lot # 25005289),
and 1% Antibiotic-Antimicotic Solution (Sigma Aldrich,
catalog # A5955).
H9C2s were seeded in the previously described Cell-Tak
coated 96-well Seahorse microplates at 25,000 cells/well.
The seeded microplates were incubated for 48 h at 37 °C
before introducing experimental conditions to the cells.
Each well was washed with 1X PBS (phosphate buffered
saline) prior to the addition of 200 μl of experimental
solution or control media. Experimental groups included
Celsior® (Sanofi, Bridgewater, NJ), Perfadex® (XVIVO
Scientific Animation, Wethersfield, CT), Somah (Somahlu-
tion®, Jupiter, FL) solutions, 1X PBS, and standard H9C2
media. The microplates were then exposed to either 4 °C or
21 °C for 4-h and 8-h time points. The 10 experimental
groups were named 4CEL, 21CEL, 4PER, 21PER, 4SOM,
21SOM, 4PBS, 21PBS, 4MED and 21MED to indicate the
temperature condition and storage solution of each group:
CEL =Celsior®, PER = Perfadex®, SOM= Somah, and MED
=media. Each treatment group consisted of 12 wells and
each microplate included all of the experimental groups.
Each experimental condition was repeated twice using
freshly made solutions and a separately started H9C2 cell
line. After each experiment, supernatant from each group
was collected and snap-frozen for High Performance Liquid
Chromatography (HPLC) analysis.
Mitochondrial stress test
Immediately after administering the experimental treat-
ments, mitochondrial respiration of H9C2 cells was
assessed using XFe96 Extracellular Flux Analyzer (Seahorse
Biosciences, North Billerica, MA). Oxygen consumption
rates (OCR) were measured in the presence of oxidative
phosphorylation (OXPHOS) driving substrates. After 3
basal measurements, 3 measurements each were taken
after the addition of oligomycin, FCCP, and rotenone/
antimycin A combination. These injected drugs block
ATP synthase, uncouple the oxygen consumption from
ATP synthesis, and block mitochondrial complexes I
and III, respectively. Results were then used to calculate
the respiratory control ratio (RCR) and coupling efficiency
(CE), which were the primary outcome measurements
along with basal respiration. RCR was calculated by the
following equation: proton leak ÷ maximal respiration;
and CE by the following equation: [(basal respiration –
proton leak) ÷ (basal respiration)] * 100.
Statistical analysis
The data were analyzed as a split-plot design. A plate
was considered a “whole plot” with treatments: time,
temperature, and the time-temperature interaction. Each
solution was considered the split-plot treatment with in-
dividual wells used as the experimental unit for a solu-
tion. Where there was a statistically significant (alpha =
0.05) effect of the solution, Tukey’s HSD was used to
compare all pairs of solutions for differences in mean re-
sponse. Where there was a statistically significant inter-
action effect involving a solution, a slice was conducted
to test the significance of drug at each level of time,
temperature, and/or time-temperature combination and
all pairs of solutions were tested for differences in mean
response at each level of the time and/or temperature,
again, using Tukey’s HSD multiple comparison procedure.
Initial analysis suggested non-constant variance among
treatment combinations. Therefore, a weighted analysis
was conducted using the inverse variance for each solu-
tion treatment-plate combination as the weight. All ana-
lyses were conducted using SAS PROC MIXED.
Results
An overall flow chart of the experimental setup and result-
ant data plotted under the 4 °C and 21 °C temperature
conditions is shown in Fig. 1. Tukey’s HSD was used for
pairwise comparisons of solutions for differences in mean
response under each respective time and temperature
condition. Only organ preservation solution pairwise
comparisons with at least a significance of alpha = 0.05 are
mentioned in the figure legends for each experimental
condition (Figs. 2, 3, 4 and 5).
Hour experiments
Comparisons of different solutions are presented in
Figs. 2 and 3, showing experiments conducted at 4C and
21C, respectively. H9C2 cells in 4SOM and 4PER both
showed a higher mean basal oxygen consumption rate
(OCR) than cells treated with either 4CEL, without sig-
nificant differences between 4SOM and 4PER. H9C2
cells in 21SOM solution showed a higher mean basal
OCR than H9C2s in 21CEL or 21PER.
At the 4 h time point, 4SOM and 21SOM treated cells
had a higher OCR than cells in 4MED and 21MED,
respectively. 4SOM also had a higher coupling efficiency
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(CE) than 4CEL and 4PER, and 21SOM showed a higher
CE than 21PER at 4 h. 4SOM showed a higher respira-
tory control rate (RCR) than both 4CEL and 4PER.
21MED showed decreased CE in comparison to
21SOM. 21MED had higher RCR values than all other
solutions.
Hour experiments
Comparisons of different solutions are presented in
Figs. 4 and 5, showing experiments conducted at 4C and
21C respectively. After 8 h, H9C2s in 4SOM had a
higher basal OCR than cells in 4PER and 4CEL. The
significant elevation in basal OCR seen in 21SOM during
the 4 h experiment did not persist after 8 h.
4SOM had a higher CE than 4CEL; 21SOM had a
higher CE than 21CEL and 21PER. 4SOM also showed
this same RCR trend above 4CEL and 4PER. As seen in
the 4 h experiments, 21MED had a lower CE than
21SOM. Finally, 21MED had a higher RCR than the
other solutions, in accordance with the trend seen dur-
ing 4 h experiments.
Discussion
The goal of this study was to evaluate H9C2 cellular
bioenergetics following a protocol designed to simulate
cardiac transplantation by using clinically relatable
temperatures and time points. To create this scenario,
cells were submerged in Somah, Celsior®, or Perfadex®
preservation solutions for 4 and 8 h either at room
temperature (21 °C) or “on ice” (4 °C). Normal saline
(phosphate buffered saline; PBS) without substrates
was chosen as the negative control since the osmotic
gradient of cells was expected to be preserved with
cellular function steadily declining as endogenous en-
ergy stores were depleted. In contrast, normal H9C2
media acted as the positive control since this media is
supplemented with the ideal growth substrates for this
cell line at 37 °C.
Fig. 1 Experimental Design Flow Chart. The conditions of the experiment were performed as shown, with data plotted for both 4 and 8 h time
points under 4 °C in panels a-c and under 8 °C in panels d-f
Fig. 2 Experimental Conditions at 4 h in 4 °C. For basal respiration (a), coupling efficiency (b) and respiratory control ratio (c), there is significance
between the Somah-Celsior® pairwise comparisons. For basal respiration (a), there is significance between Celsior- Perfadex pairwise comparisons ®. For
coupling efficiency (b) and respiratory control ratio (c), there is significance between Somah-Perfadex® pairwise comparisons. Error bars shown are SEM
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While cultured primary cardiomyocytes are a valuable
tool for studying the metabolic capacity of the heart, iso-
lated cardiomyocytes can be fragile and difficult to main-
tain, especially under stress. As a result, the H9C2 cell line
was chosen because these cells express multiple CYP
genes comparable to the levels found in the human heart
[9]. The role of these endogenous CYP metabolites has
been shown to be important in the maintenance of cardio-
vascular health, and therefore offers an unique model for
studying the metabolic activity of the heart [9].
It was hypothesized that the ideal preservation solution
could create a state of suspended animation, in which
cellular function and metabolism could be preserved for
an extended period of time with the least amount of
resultant metabolic dysfunction. Altered cellular metabol-
ism is a more sensitive indicator of stress than some
traditional outcome measures that may take time to accu-
mulate and detect (e.g., DNA and protein analyses). The
role of mitochondria in ischemic reperfusion injury during
cardiac transplant is becoming increasingly evident [10].
Safeguarding mitochondrial bioenergetics could play a key
role in improving transplant outcomes. Thus, to examine
this endpoint, extracellular flux analyses were used to
compare mitochondrial respiration of H9C2s after each
treatment condition. Targeting various complexes and
pathways in the mitochondria allowed us to identify any
changes in substrate metabolism and mitochondrial (dys)-
function. Basal respiration was analyzed as a baseline bio-
energetic measurement for each experimental condition.
The basal respiration is often controlled by high ATP
turnover, and in part dictated by substrate oxidation and
proton leak [11]. This measure is therefore altered in
response to ATP demand. Coupling efficiency and respira-
tory control ratios were analyzed since both parameters
are ratios, and are therefore useful internal controls that
are unaffected by differences in cell number. Additionally,
changes in CE and RCR are good indicators of cellular
and mitochondrial dysfunction.
Overall, Somah had a greater OCR than both treatment
and control groups. This finding was statistically sig-
nificant after 4 h at room temperature (21 °C) com-
pared to Celsior® and Perfadex®. Compared to the
control media, the OCR of Somah-treated H9C2s
(4SOM and 21SOM) were increased compared to the
Fig. 3 Experimental Conditions at 4 h in 21 °C. For basal respiration (a), there is significance between the Somah-Celsior® and Somah-Perfadex®
pairwise comparisons. For coupling efficiency (b), there is significance between the Somah-Perfadex® pairwise comparison. For respiratory control
ratio (c), there is no significance between the pairwise comparison of the organ preservation solutions (Somah, Celsior® and Perfadex®). Error bars
shown are SEM
Fig. 4 Experimental Conditions at 8 h in 4 °C. For basal respiration (a) coupling efficiency (b) and respiratory control ratio (c), there is significance
between the Somah-Celsior®, and Somah-Perfadex® pairwise comparisons. Error bars shown are SEM
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control media (Figs. 2 and 3) at both 4o and 21 °C after
4 h of incubation. By 8 h, the media and the preserva-
tion solution conditions become similar and the signifi-
cant trend diminishes. 4SOM had an increased OCR
value compared to 4PER and 4CEL experimental
groups, as well as 4MED and 4PBS controls. Also at the
8-h time point, 21PBS had a significantly lower OCR
than the other treatment groups, while 21SOM, 21CEL
and 21PBS have similar OCR values. As expected, PBS
was overall the least-ideal solution since it has the low-
est OCR. At 4 h under both temperature conditions,
the differences between all solutions, and notably PBS,
were not obvious. This is likely due to the resiliency of
the H9C2 cell line, reiterating why this cell line is a
good model for investigating metabolic activity and
drug metabolism in the heart [9]. An aim for a future
study may include longer time points such as 12 or
24 h, though organs stored for extended periods of time
are not considered clinically viable.
The basal respiratory OCR of Somah-treated cells was
greatest and allowed cells to maintain metabolism at a
more consistent OCR through the 4-h time point (Figs. 2
and 4). In comparison, base media, Celsior®, and Perfadex®
took up to 8 h to return to a higher OCR at 21 °C (Figs. 3
and 5). These same differences are even more pronounced
at 4 °C, where 4CEL is found to have a lower OCR than
both 4PER and 4SOM.
Coupling efficiency (CE) is defined as the proportion
of mitochondrial respiratory rate used to drive ATP syn-
thesis (e.g., perfectly coupled OXPHOS has a coupling
efficiency of 100%) [12]. CE is calculated as the change
in basal respiration rate with the addition of oligomycin,
and is thus presented as the fraction of basal mitochon-
drial oxygen consumption used for ATP synthesis. Since
it takes the basal respiration into account, the CE also
varies with ATP demand and is most sensitive to changes
in proton conductance. Since CE is a ratio of two rates, it
is an internally normalized value and can indicate
mitochondrial dysfunction. Overall, both Somah and
media treated cells have a high CE (90%), which shows
that even though maximal respiration may be damaged
(see RCR), the normal ATP turnover when compared to
the leak of protons over the membrane has not changed.
After both 4 and 8 h at 4 °C, the CE of H9C2s treated with
either Somah or media was significantly higher than all
other solutions (Figs. 2 and 4) and Celsior® and Perfadex®
were not significantly different at either time point. The
shorter time point of 4 h led to a higher CE in Somah over
the other solutions. 4SOM is comparable to the media
control condition, while at 21SOM the CE was signifi-
cantly lower than compared to Celsior® and Perfadex®, yet
the CE of media treated cells remained significantly higher
than the other groups. This might be due to an increased
proton leak or a decrease in ATP production. If caused by
a rise in proton leak, there might be an increased produc-
tion of superoxide anions and other ROS that cause tissue
or organ damage. In previous research, Somah has shown
to function best at 21 °C [8]. This is an interesting link to
our significantly lowered CE result and should be the
subject of future research. However, given the similar-
ities between Somah and media treatments in the
hypothermic conditions of this experiment, Somah is
considered preferred at 4 °C, while media is favored at
a warmer temperature.
The respiratory control ratio (RCR) is calculated as a
ratio of the uncoupled rate of mitochondrial respiration
to the rate with ATP synthase inhibited by oligomycin.
The RCR is sensitive to changes in substrate oxidation
and proton leak, which makes it sensitive overall to po-
tential dysfunction [11]. One major benefit of the RCR
as a measurement is that it is internally normalized,
similar to CE. At 4 h, 4SOM results in a higher RCR
than H9C2s treated with either 4CEL or 4PER, but has a
similar RCR to media. Similar to the CE results, this
change is attributable to either an increase in proton
leak or a decrease in maximal ATP turnover, or a
Fig. 5 Experimental Conditions at 8 h in 21 °C. For basal respiration (a) and respiratory control ratio (c), there is no significance between the
pairwise comparisons of the organ preservation solutions. For coupling efficiency (b), there is significance between the Somah-Celsior®, and
Somah-Perfadex® pairwise comparisons. Error bars shown are SEM
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combination of both. Unlike the CE results, the RCR of
Somah-treated cells remains significantly higher than all
of the other solutions over the entire 8 h. 21MED also
has a high RCR over both 4 and 8 h, with significance
over all other treatment groups. As expected by 8 h,
21PBS has the lowest RCR of all groups. The experimental
group most similar to the media-treated cells was the
Somah-treated cells. While Somah best maintained a high
RCR under hypothermic conditions, media maintained a
high RCR at warmer room temperature conditions.
A notable limitation of the study is the limited number
of storage solutions included in the comparison. As previ-
ously mentioned, there are numerous organ storage solu-
tions currently available, and even more in development.
Therefore, an aim in future studies includes incorporating
more organ storage solutions into this experimental de-
sign, including UW solution, Custodiol, histidine trypto-
phan ketogluterate (HTK), and Collins storage solutions.
Another limitation was the use of non-human tissue
for the measurement of bioenergetic values. While car-
diomyocytes of multiple animal models closely resemble
that of a human, it can still be difficult to draw solid
conclusions regarding the clinical value of the findings
presented. Even though this concern is valid, this study
demonstrates a reliable and elegant method of measur-
ing the bioenergetic profile of cardiac cells lines during
storage in various solutions. Therefore, based on the
methodology and experimental results, the results from
this experiment can be extrapolated for translation to
human tissue. It is important to establish non-human
models since healthy human cardiac tissue is scarcely
available. Despite these limitations as a clinical model,
the results of this study suggest differences in metabolic
preservation between the solutions, with Somah being
the optimal preservation solution.
Additionally, the model explored in this study is lim-
ited by the fact that the cells are seeded in a monolayer,
and not multi-layered as seen in an organ. The use of
tissue biopsies has been very challenging, as the mito-
chondrial stress test performed in these assays is an
extremely precise procedure, in which exact cell number
are crucial when injecting different drugs in the wells of
the assay plate.
Future studies to use multi-layer cardiac myoblast cul-
ture as well as creating micro-tissues by co-culture with
fibroblasts and cardiac myocytes would provide key three-
dimensional bioenergetic data. Currently, these culture
techniques are being developed with collaborators, as
extracellular flux analyzers currently do not provide
consistent and homogenous data that is reportable for
these types of cultures. The benefit, on the other hand,
of a single layered model is that these assays provide
very accurate results, without any interference of other
processes. Thus, these monolayer experiments serve as
the first confirmatory step that protecting cellular
mitochondrial integrity of transplantable organs may
lead to improved organ function, reduced IRI and
better transplant outcomes.
Conclusions
These results suggest Somah solution sustains a higher
and more consistent OCR when compared to both Celsior®
and Perfadex® at 4 °C, and these effects can last from 4 h
up to 8 h. These findings are additionally supported by
current literature [8]. Given these results, Somah offers
benefits over the solutions at 4 °C and should be a target in
future organ preservation solution research.
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